
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene — making it one of the first characterized "mitochondrial-derived peptides" (MDPs). Identified in 2015, it is an active area of research in mitochondrial bioenergetics and metabolic homeostasis.
Published studies describe MOTS-c translocating to the nucleus under metabolic stress, modulating AMPK pathway activation, and influencing insulin sensitivity and mitochondrial biogenesis in animal models.
Characterized and named by the Lee laboratory at USC in 2015. Represents a growing class of short peptides encoded by mitochondrial DNA that participate in cellular signaling.
Published research literature covers the following areas:
LAR supplies this compound as a reference standard to qualified laboratories. No dosing schedules, administration methods, or human-use guidance is provided or implied.
Sealed vial: Stable at refrigerated temperatures (2–8 °C) for up to 24 months. Stable at room temperature (up to 25 °C) for 30 days during shipping.
After opening: Refrigerate at 2–8 °C and use within 30 days. Protect from light. Do not freeze after opening.
Visual check: Solution should remain clear. Discard if discoloration or precipitate appears.
Every batch is independently tested for purity, mass, and endotoxin load. Click any report to view the full analysis.
No. Research peptides supplied by LAR are reference materials for laboratory investigation. They are not approved by the FDA or any national regulatory body for human use.
Yes. Vials ship as lyophilized powder, giving your lab control over solvent selection and final concentration. Reconstitution should follow your laboratory's standard practice.
Each manufacturing batch is tested by an independent third-party laboratory using HPLC-UV analysis. The full report, including chromatogram and mass spectrometry, is available above.
Orders ship within 1–2 business days via discreet packaging.